KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo

Table 1

Relationships of KIF5A and clinicopathological characteristics in 115 patients with BC.

Feature	All ()	KIF5A expression
		Low	High
		Age (year)						2.184	0.139
<65	46	18	28
≥65	69	18	51
Gender				0.332	0.565
Male	99	30	69
Female	16	6	10
Tumor stage				13.431	0.000
T2	54	26	28
T3/T4	61	10	51
Tumor grade				5.830	0.016
Low	64	26	38
High	51	10	41
Lymph node metastasis				1.669	0.196
Yes	35	8	27
No	80	28	52
Recurrence				1.948	0.163
Yes	59	15	44
No	56	21	35
Distant metastasis				1.408	0.235
Yes	33	13	20
No	82	23	59
Vascular invasion				0.208	0.648
Yes	35	12	23
No	80	24	56